Related Experiment Video
Updated: Jun 9, 2026

Rodent Inferior Vena Cava Venoplasty Balloon Model
Published on: May 24, 2024
[Vena cava filters in trauma patients]
D Baschera1, J Sebunya, C Walter
1Department of Orthopaedic and Trauma Surgery, Royal Perth Hospital, North Block, Level 5, Wellington Street, 6000, Perth, Australien. dbaschera@bluewin.ch
Removable inferior vena cava filters (IVCF) are increasingly used in trauma patients for pulmonary embolism prevention. Clarifying removal responsibility is crucial to improve retrieval rates for these devices.
Area of Science:
- Medical Devices
- Vascular Surgery
- Trauma Care
Context:
- Inferior vena cava filters (IVCF) offer new options for preventing pulmonary embolisms in surgical trauma patients.
- Observational data indicates a rising trend in IVCF utilization within trauma populations.
- A level 1 trauma center analyzed IVCF use in 85 patients during 2008.
Purpose:
- To evaluate the indications and outcomes of IVCF placement in trauma patients.
- To assess the retrieval rates and challenges associated with IVCFs in this cohort.
- To identify areas for improvement in IVCF management and utilization.
Summary:
- A retrospective analysis included 49 trauma patients who received IVCFs.
- Indications included multiple trauma (33), severe head injury (13), and spinal injury (3).
- Successful retrieval was achieved in 34 patients; 11 (22%) had no retrieval attempt, and 3 had unsuccessful attempts.
Impact:
- The majority of IVCFs were placed for prophylaxis in trauma patients in 2008.
- Clarifying responsibility for IVCF removal is essential to enhance retrieval rates.
- Further research, including randomized controlled trials, is needed to define optimal IVCF use in trauma patients.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Hemodialysis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
